Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2423 in moderate to severe COPD
NCT01215279Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of azd2423 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Oct 2010; status: completed.
02
Drugs
azd2423
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01215279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215279.